Employment

• 2008-present, Head, Laboratory of Pharmacokinetics and Therapeutic Drug Monitoring, Unit of Clinical Pharmacology, L. Sacco University Hospital, Milano, Italy
• 2016-present, Coordinator of the outpatient clinics for the management of polytherapies in HIV-infected patients, L. Sacco University Hospital, Milano, Italy
• 2004-2013, Component (Pharmacologist) of the Ethical Committee of the Scientific Institute E. Medea, Bosisio Parini, Lecco, Italy
• 2003-2008, Component (Pharmacologist) of the Ethical Committee of the Bolognini Hospital of Seriate, Bergamo, Italy
• 2004-2008, Head, Unit of Pharmacology and Pharmacogenetics, Mario Negri Institute for Pharmacological Research, Bergamo, Italy
• 1997-2003, Research fellow, Mario Negri Institute for Pharmacological Research, Bergamo, Italy

Academic commitments

• 2010-present, Assistant professor in Pharmacology, Faculty of Medicine, University of Milano, Italy
• 2003-2011, Assistant Professor, Master in Transplant Medicine, University of Milano Bicocca, Italy
• 2005-2008, Educational coordinator, Maastricht University (Belgium), within the Research Elective Agreement with the Mario Negri Institute for Pharmacological Research, Bergamo, Italy
• 2004-2008, Assistant Professor, Master in Clinical Research, University of Milano, Italy
• 2013-2017, Assistant Professor, Master in Pharmacovigilance and Pharmacoepidemiology, University of Naples, Italy

Education & Certification

• 1984-1989, High school diploma in Chemistry (Bergamo, Italy)
• 1990-1995, Pharmacy Degree (University of Milano, Italy)
• 1997-2000, Post-graduation specialization in Pharmacological Research (Mario Negri Institute for Pharmacological Research, Bergamo, Italy)
• 1998-2001, Post-degree Specialization in Pharmacology (University of Milano, Italy)
• 2001-2005, PhD in Biomedical Sciences (Open University, London, UK)

Professional Activities

• 2005-present, International Association of Therapeutic Drug Monitoring and Clinical Toxicology
• 2006-present, Italian Society of Pharmacology
• 2016-present, Italian Society of Infectious Diseases and Tropical Medicine
• 2019-present, European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
• 2009-2016, American College of Clinical Pharmacology
• 2018-present, Italian Federation of Human and Animal Mycology

Awards

• 2001, Winner of the E. Cofferati award for the research activity in the field of immunosuppressant pharmacology
• 2010, Winner of the D.E.I. Onlus Foundation award for the best emerging profiles in the field of clinical pharmacology

Publications / scientific activities

• Author of nearly 250 publications on peer reviewed indexed international journals, cited more than 6500 times, H-index: 38
• 7 book chapters
• Invited speaker for nearly 50 international congresses
• Invited speaker for nearly 200 national congresses
• Referee activities for dozens of indexed international journals (> 500 manuscripts reviewed)
• Member of the editorial board of European Journal of Drug Metabolism and Pharmacokinetics
• Member of the editorial board of Therapeutic Drug Monitoring
• Vice chair of the anti-infective committee within the IATDMCT society
• Member of the ESCMID PK/PD of Anti-Infectives Study Group
• Member of the board of directors of the Italian Federation of Human and Animal Mycology

Main clinical/research activities

• Therapeutic drug monitoring (mainly anti-infective agents, immunosuppressants, and central nervous system drugs)
• Pharmacokinetic studies both in healthy volunteers and in patients
• Application of pharmacogenetics as diagnostic tool for the optimization of drug therapies
• Antimicrobial stewardship
• Study and assessment of potential drug-drug interactions in real life settings
• Evaluation of potential inappropriate drug prescribing in fragile patients (deprescribing)
• Development and validation of analytical methods for the quantification of drugs in different biological matrices

Vision Statement

I envisage the future of the IATDMCT society as the key player for the tailoring of drug therapy in increasingly complicated patients (elderly, with comorbidities and heavy polypharmacy) at the bedside, taking advantage from the presence of active members with excellences and expertise in several fields. The accomplishment of this task requires, however, a day-by-day, two-way strict collaboration with specialists from different medical disciplines. In other words, the labs need to meet/match the clinics!

Employment

• 2021-present, Advanced Research Project Professor, Pharmacometrics and Systems Pharmacology, Keio University Tonomachi Town Campus, Japan
• 1998-2021, Professor, Department of Clinical Pharmacokinetics and Pharmacodynamics, Keio University School of Medicine, Japan
• 1998-2007, Director of Hospital Pharmacy, Keio University Hospital, Japan
• 1993-1998, Associate Professor and Vice Director, Department of Pharmacy, Kobe University Hospital, Japan
• 1991-1992, Honorary Research Fellow, School of Pharmacy, University of Manchester, U.K.
• 1990-1993, Lecturer, Department of Pharmacy, Kyoto University Hospital
• 1985-1990, Instructor, Department of Pharmacy, Kyoto University Hospital

Education & Certification

• JSPHCS-certified Senior Oncology Pharmacist (JSOP), Japanese Society of Pharmaceutical Health Care and Sciences
• Board Certified Oncology Pharmacy Specialist (BCOPS), Japanese Society of Hospital Pharmacists
• Board Certified Supervisor Pharmacist, Japanese Society of Clinical Pharmacology and Therapeutics
• Board Certified Pharmacist, Japanese Society of Clinical Pharmacology and Therapeutics
• Pharmacist License of Japan
• 1983, Ph.D. from Graduate School of Pharmaceutical Sciences, Kyoto University, Japan
• 1980, MSc from Graduate School of Pharmaceutical Sciences, Kyoto University, Japan
• 1978, BSc from Faculty of Pharmaceutical Sciences, Kyoto University, Japan

Professional Activities

• 2019-2021, IATDMCT President
• 2017-2019, IATDMCT President-Elect
• 2013-2017, IATDMCT Secretary (2 terms)
• 2017, Chairman, 15th IATDMCT Congress 2017 in Kyoto
• 2015-2017, Chair of Scientific Committee “TDM in Oncology”
• Editorial Board, Therapeutic Drug Monitoring
• 2005-2011, President, Japanese Society of Therapeutic Drug Monitoring (JSTDM)
• Plenary Lecturer at 14th Congress of IATDMCT 2015 in Rotterdam
• Plenary Lecturer at 12th Congress of IATDMCT 2011 in Stuttgart
• Invited speaker at IATDMCT Regional Meeting in Guangzhou, China, 2016
• Invited speaker at IATDMCT Regional Meeting in Sibiu, Romania, 2014
• Invited speaker at IATDMCT Regional Meeting in Beijing, China, 2010
• Symposium speaker and organizer at the IATDMCT Congresses (Vienna in 1995, Cairns in 1999, Montreal in 2009)
• Number of peer reviewed original articles: 183
• Book chapters and Review articles: 250
• Invited lectures at international conferences: 46
• Invited lectures at Japanese national conferences: 117
• Dr. Tanigawara was distinguished as “Highly Cited Researcher” by Thomson Reuters ISI database. His research interests include clinical pharmacokinetics, pharmacodynamics and pharmacogenomics and their applications to TDM. He also investigates multi-omics biomarkers by means of MS-based proteomics and metabolomics.

Other academic and professional appointments

• 2003-present, Executive Board member, Japanese Society of Therapeutic Drug Monitoring (JSTDM)
• 2015-present, Executive Board member, Japanese Society of Clinical Oncology (JSCO)
• 2018-2020, Secretary of International Society of Pharmacometrics (ISoP)
• 2006-present, President, Population Approach Group in Japan (PAGJA), which was renamed as ‘Pharmacometric Approach Group in Japan’
• 2016-present, Co-chair, Focus Group “Modeling and Simulation,” International Society for Study of Xenobiotics (ISSX)
• 2011, Fellow of the Japanese Society for Study of Xenobiotics (JSSX)
• 2007-2009, Delegate for the Board of Pharmaceutical Sciences, International Pharmaceutical Federation (FIP)
• 2005-2008 and 2010-2014, Executive Board member, Japanese Society of Clinical Pharmacology and Therapeutics
• 2008-2016, Executive Board member, Japanese Society of Pharmaceutical Health Care and Science
• 2007-2009, Executive Board member, The Pharmaceutical Society of Japan
• 2005-present, Council member, Japanese Society of Clinical Oncology
• 2007-present, Council member, Japanese Society of Medical Oncology
• 2009-present, Council member, Japanese Cancer Association
• 2003-present, Council member, Japanese Society of Chemotherapy
• 2003-present, Council member, Japanese Society for Pharmacoepidemiology
• 2002-present, Associated Editor, Cancer Science
• 2005-present, Editorial Board, Japanese Journal of Clinical Oncology
• 2010-present, Editorial Board, The Japanese Journal of Antibiotics
• 1999-2001, Editorial Board, European Journal of Pharmaceutical Sciences

Employment

• Since 2019 (professor of Clinical Pharmacy)
  • University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia
  • Westmead Hospital, Western Sydney Local Health District, Sydney, Australia
• 2013-2018 (hospital pharmacist – associate professor)
  • University Medical Center Groningen, Groningen, the Netherlands
• 2009-2013 (hospital pharmacist – assistant professor)
  • University Medical Center Groningen, Groningen, the Netherlands
• 2005-2008 (hospital pharmacist – in residency)
  • University Medical Center Groningen, Groningen, the Netherlands
• 2002-2004 (pharmacist)
  • University Medical Center Groningen, Groningen, the Netherlands

Education & Certification

• 1995-2000 University of Groningen, MSc of Pharmacy
• 2000-2002 University of Groningen, PharmD
• 2005-2008 University Medical Center Groningen, residency in Hospital Pharmacy
• 2006-2009 University of Groningen, PhD in Medicine
• 2009-2011 University Medical Center Groningen, specialty training in Clinical Pharmacology

Professional Activities

Memberships: IATDMCT, NVZA (Dutch Society of Hospital Pharmacists), NvKFB (Dutch association for Clinical Pharmacology and biopharmaceutics), KNMP (Royal Dutch Society of Pharmacy), The International Union Against Tuberculosis and Lung Disease, ESCMID (European Society of Microbiology and Infectious Diseases, ASID (Australasian Society of Infectious Diseases, ISAP (International Society of Anti-Infective Pharmacology), ASM (American Society for Microbiology)

Committees: member of Human Ethics Research Committee, member of Scientific Advisory Committee, member of Clinical Trials Advisory Committee, member of Drug Committee WSLHD, Global Tuberculosis Network – Clinical Pharmacology Committee (chair)

IATDMCT activities: editorial board member TDM, past vice chair/past chair Anti-infective committee, past vice chair/past chair/current vice chair of Alternative Sampling Committee, Local Scientific advisory Committee IATDMCT Conference 2015, recipient of Victor Armstrong Young Investigator award 2015

Professional appointments: editorial board member Journal of Mass Spectrometry & Advances in the Clinical Lab, associate editor International Journal of Tuberculosis and Lung Disease, Expert advisor on Clinical Pharmacology of TB drugs WHO-ERS-ECDC Concilium

Number of publications: 301 publications in peer reviewed journals

Invited speaker: > 80 invited lectures on national and international conferences

Vision Statement

To influence patient-centred therapeutic drug monitoring and clinical toxicology at a global level, the IATDMCT should embrace international collaborative multidisciplinary research, thereby delivering high impact research. By developing an interactive regional training, education and professional development program, focused on early career researchers and clinicians, the IATDMCT will be positioned to attract creative and inspiring leaders of the future to deliver its promise to patients and their families to improve their health and well-being.

Employment

• Head of The Laboratory for Renal Physiology, Oslo University Hospital-Rikshospitalet, Oslo, Norway [2013- ].
• Professor, Department of Pharmacy, University of Oslo, Norway [2004- ].
• CEO, The Norwegian Renal Registry [2014- ].
• Medical Manager (Hospital) and Product Manager (Transplantation), Roche Norway [2000-04].

Education & Certification

• PhD 1999: "Effects of cyclosporine A on microvascular function and endothelin-1 in renal transplant recipients", University of Oslo, Norway.
• M.Sc. (Pharm) 1995: "Effects of diltiazem in cyclosporine treated renal transplanted patients", University of Oslo, Norway.
• High-school engineer, Åsö Technical High-school, Stockholm, Sweden.

Professional Activities

Administrative:

• Editorial board of Therapeutic Drug Monitoring [2016- ].
• Secretary for The Norwegian Society of Pharmacology and Toxicology [2006-08].
• Leader of the dissemination committee, School of Pharmacy, University of Oslo [2005-11].
• Vara for part time position personnel at the Institute board at Department of Pharmacy, University of Oslo [2017-18 & 2021- ].
• Steering Committee member of the joint International Society of Pharmacometrics (ISoP) and the American College of Clinical Pharmacology (ACCP) Clinical Pharmacometrics Special Interest Group (ISoP-ACCP SIG); “Patient Centered Pharmacometrics SIG” [2017- ].
• Manager in PharKin, consultant company in pharmacology, Norway [1998-2020].
• Vice-president in Pharmacists Athletic Club, Norway [1997-99].
• Board member in Pharmacists Athletic Club, Norway [1996-97].
• President in the pharmacist’s student organization "Veneficus" [1992-93].

Clinical trials:

• Member of the Study Management Team of the international multi-centre trial “VICTOR”; ganciclovir versus valganciclovir for treatment of CMV disease in solid organ transplant recipients [2004-16].
• Leader of the Steering Committee in the national clinical trial “COCKTAIL”; impact of body weight, low calorie diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers in morbidly obese patients [2014- ].
• Member of the Steering Committee of the national single centre trial “IBANTx”; ibandronate in renal transplant recipients [2006-14].
• Management Committee member, COST action BM0702 (Urine & Kidney Proteomics) [2010-12].

Scientific:

• > 200 peer reviewed papers, 1 book chapter, Google Scholar h-index: 45, i10-index: 114, citations: 7241.
• Contributed to three international guideline/consensus papers; tacrolimus [PMID: 31045868], mycophenolate [PMID: 33711005] and CMV [PMID: 20224515, 23896556] in solid organ transplant recipients.
• Supervised; 3 Postdocs, 18 PhD, 53 Master, 4 Bachelor.
• Best Reviewer Award 2018 and 2019 – In recognition of an outstanding contribution to the quality of the journal, Therapeutic Drug Monitoring.
• Visiting scholar for 1 year at the Laboratory for Applied Pharmacokinetics, University of Southern California/Children's Hospital Los Angeles, Los Angeles, CA, USA [2012-13].

Memberships:

• The International Association of Therapeutic Drug monitoring and Clinical Toxicity (IATDMCT)
• The Norwegian Society of Pharmacology and Toxicology (NSFT)
• The Transplantation Society (TTS)
• The European Society of Organ Transplantation (ESOT)
• American Society of Transplantation (AST)
• The Norwegian Society for Nephrology (NNF)

Vision Statement

Patient-centered monitoring and treatment of patients utilizing front line analytical and biostatistical tools. The members of IATDMCT embraces the core functions of tomorrows advanced monitoring and treatment individualization. Our involvement in utilizing already developed tools (e.g. capillary micro sampling, advance matrix analyses, population models) and investigating new options (e.g. machine learning) will be vital for implementation of true patient-centered therapy in the clinic in cooperation with clinicians and specialists in other medical disciplines.

Employment

• 2019 - present: Full Professor and Deputy Dean of the Faculty of Health Science, University of Pretoria
• 2015 – 2019 (31 Aug): Full Professor and Head of Department of Pharmacology, University of Pretoria
• 2010-2015 (31 Oct): Associate Professor, Department of Pharmacology and Head of Phytopharmacology, University of Pretoria
• 2004 – 2009: Senior Lecturer, Department of Pharmacology, University of Pretoria
• 2002 – 2004: Senior Lecturer, Department of Urology, University of Pretoria
• 1998 – 2002: Lecturer and Researcher, Indigenous Toxicology Unit, Department of Chemical Pathology, National Health Laboratory Services and University of the Witwatersrand Medical School, Johannesburg, South Africa
• 1991 – 1998: Researcher, Department of Endocrinology, South African Institute for Medical Research, Johannesburg
• 1988-1991: Junior Lecturer, Department of Zoology, University of Pretoria, Pretoria

Education & Certification

Education:

• 2001: PhD (Med), Clinical Toxicology, Department of Chemical Pathology, University of the Witwatersrand, South Africa
• 1995: Higher Educational Degree (post graduate) (cum laude), University of South Africa, South Africa
• 1991: MSc (cum laude), Biochemistry, University of Pretoria, South Africa
• 1987: BSc (Hons), Zoology, University of Pretoria, South Africa.

Certification:

• Health Professions Council of South Africa: Medical Scientist (MW0005916)
• South African Council for Natural Scientific Professions: Professional Biological Scientist (Registration No. 400180/09)
• South African Council for Natural Scientific Professions: Professional Toxicologist (Registration No. 400180/09) in the field Toxicological Sciences [2009- ]

Professional Activities

Membership of scientific societies:

• The International Association of Forensic Toxicologists [2019- ]
• The Society for Medicinal Plants and Economic Development [2016- ]
• Chromatographic Association of South Africa [2001 - ]
• International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) [1999-]
• International Society of Ethnopharmacology [2002- ]
• Pharmacology for Africa [2008- ]
• Toxicology Society of South Africa [2002- ]
• Society of Toxicology [2014 - ]
• South African Association of Clinical Biochemistry [1992- ]
• South African Society for Basic and Clinical Pharmacology [2007- ]
• American Association for Clinical Chemistry (AACC) [2002-2010]
• Clinical Ligand Assay Society [2006-2007]

Positions in organizations/committees:

National
Executive Council Member:
Current

• Past-President: Federation of the South African Societies of Pathology (FSASP) (2017 -2021)
• President: South African Society for Basic & Clinical Pharmacology (2017- )
• Vice-President: Toxicology Society of South Africa (2006 – )
• Committee Member: International Science Council Regional Office for Africa, representing Pharmacology (2018 - )

• Committee Member: South African National Committee for the International Union for Basic and Clinical Pharmacology (2013 - 2017)
• Past-President: South African Association of Clinical Biochemistry (2010–2016)
• Vice-President: South African Society for Basic & Clinical Pharmacology (2014-2017)
• Secretary-General: South African Society for Basic & Clinical Pharmacology (2007-2014)
• President: Federation of the South African Societies of Pathology (2014 -2017)
• Treasurer: Federation of the South African Societies of Pathology (FSASP) (2007-2013)
• President: South African Association of Clinical Biochemistry (2005 – 2010)
• Councilor: Toxicology Society of South Africa (2002 – 2006)
• Treasurer: South African Association of Clinical Biochemistry (2001 – 2005)

Other
Current:

• Member: South African Committee of Medical Deans (2019 -)
• Steering Member: South African Committee of Medical Deans, Subcommittee: Teaching & Learning (2019 - )
• Panel member: NRF Postgraduate bursaries and Travel Grants Virtual Peer Review (2019 -)
• Professional Advisory Committee: South African Council for Natural Scientific Professions (2013 -)
• Chair: PhD committee, School of Medicine, Faculty of Health Sciences, University of Pretoria (2018-2021)
• Chair: Assessment Subcommittee of the Dirisana project (EU-South Africa collaboration) (2021-2023)

• Member: Doctoral Degree Review Task Team; representing Faculty of Health Sciences (2019 - 2020)
• Committee member: Academic Advisory Committee for the School of Medicine, Faculty of Health Sciences, University of Pretoria (2008 - 2020)
• Panel member: NRF rating - Health Sciences Specialist Committee (2015-2018)
• Committee Member: PhD committee, School of Medicine, Faculty of Health Sciences, University of Pretoria (2016 - 2018)
• Committee member: Research Committee, School of Medicine (RESCOM SOM), Faculty of Health Sciences, University of Pretoria (2010 - 2016)
• Committee member: Research Development sub-committee, Faculty of Health Sciences, University of Pretoria (2012 - 2016)
• Committee member: The Research Information System Committee, Faculty of Health Sciences, University of Pretoria (2012 - 2016)
• Committee member: The Research Forum Committee, Faculty of Health Sciences, University of Pretoria (2012 - 2016)
• Committee member: The Postgraduate Scholarship Bursary Allocation Committee, University of Pretoria (2012 - 2016)
• Chair: National Meetings Committee of the FSASP (2006 - 2011)
• Committee member: University of Pretoria, Cultural Day (2003 - 2009)
• Committee member: Faculty Day Committee, Faculty of Health Sciences, University of Pretoria (2012 - 2015)
• Committee member: Postgraduate Supervisors Forum, Faculty of Health Sciences, University of Pretoria (2012 - 2016)
• Committee member: Research Forum sub-committee, Faculty of Health Sciences, University of Pretoria (2012 - 2016)

International
Executive Council Member:
Current

• Vice-Chair: International Federation of Clinical Chemistry (IFCC) Education and Management Executive Committee (2021- )

• Member: IFCC Education and Management Executive Committee (2018-2020)
• President: African Federation of Clinical Chemistry (Founding president; 2009-2013)
• Past-President: African Federation of Clinical Chemistry (2014 - 2017)
• Director of Education: International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) Executive Board (2009-2011; 2013-2015)
• Member at Large: IFCC Executive Board (2012-2014; 2015-2017)

Other

• Steering member: Clinical Toxicology and Drugs of Abuse Committee IATDMCT (2018 - )
• Steering member: Standards of Laboratory Practice IATDMCT (2008 - )

• Chair: Clinical Toxicology and Drugs of Abuse Committee IATDMCT (2013 - 2017)
• Liaison: Young Scientists Task Force to IFCC Executive Board (2017-2018)
• Member: Awards Committee IFCC (2015-2017)
• Member: International Union of Toxicology (IUTOX) nominating committee (2015 - 2017)
• Steering member: Clinical Chemistry Trainee Council Advisory Board (2011 - 2016)
• Vice-chair: Clinical Toxicology Committee IATDMCT (2008 - 2012)
• National representative: Clinical Chemistry, South Africa to the IFCC (2005 - 2011)
• Steering member: IFCC Committee for Congresses & Conferences (2009 -2011)
• Steering member: Membership Committee, Clinical Ligand Assay Society (2006 – 2007)
• International Advisory Board for the IATDMCT (2002 – 2003)

Research activities:

• Publications: 181
• Chapters in books: 7
• Conference presentations: 325
• Invited/plenary speaker: 59
• Postgraduate Student Supervision: 4 post docs; 64 to graduation (Master and PhD); currently supervising 11 students
• Reviewer for 36 journals and on the Editorial Board of 7 journals

Activities in IATDMCT:

• Member of IATDMCT since 1999
• Attended all but one conference since joining the Association, where I have actively participated in presentations, roundtables, symposiums
• Committee member, Vice-chair and Chair of the Clinical Toxicology and Drugs of Abuse Committee
• Committee member: Standards of Laboratory Practice IATDMCT (2008 - )
• Director of Education: served two terms (2009-2011; 2013-2015)
• Recipient of the first travelling lectureship awarded by the IATDMCT; visited Chile
• Several contributions to the Newsletter
• Served as Editor of the Conference Newsletter in Nice
• Acted as adjudicator for best poster awards on several occasions
• Acted as Chair/co-chair of sessions at IATDMCT conferences since 2001
• Recipient of the Young Scientist Award of IATDMCT
• Served on the International Advisory Board for the IATDMCT

Vision Statement

To remain updated with therapeutic drug monitoring and clinical toxicology in order to stimulate research and improve patient care. The latter to be governed by creating and inspiring compelling, effective deep research-driven experiences, using innovative design and best practices and embracing technology and the 4th industrial revolution. This should be applied in research, as well as conferences and must empower our young scientists with the skill set to be adapted for the place of work.

Employment

• 2016-present: Assistant Professor, Department of Pharmacology, Rennes University Hospital, Rennes
• 2012-2016: University Hospital Assistant, Department of Pharmacology, Rennes University Hospital, Rennes
• 2009-2012: Hospital Assistant, Department of Pharmacy, Hôpital La Pitié-Salpêtrière, Paris
• 2003-2009: Pharmacy residency, Rennes University Hospital, Poitiers University Hospital

Education & Certification

• 2010-2014: PhD in Experimental and Clinical Pharmacology: « Optimization of immunosuppressive therapy using pharmacological method». Paris Sud University. Faculty of Pharmacy. Ecole doctorale 425 Innovation thérapeutique : du fondamental à l’appliqué, Paris
• 2009: PharmD and Advanced Degree in Hospital Pharmacy, Rennes 1 University, Faculty of Pharmacy, Rennes
• 2008: Master in « Drug Toxicology », University Paris V, Faculty of Medicine, Paris
• 2007: University qualification in « Anti-infectious therapeutics », Rennes 1 University, Faculty of Medecine, Rennes
• 2003: Pharmacy residency national examination
• 1998/2003: Pharmacy studies, University of Caen, Faculty of Pharmacy, Caen

Professional Activities

• 2019-present: Co-coordinator of the Immunosuppressive subgroup of the national society « Société Française de Pharmacologie et Thérapeutique (SFPT) »
• 2019-present: Expert for drug-drug interactions at the French National Drug Regulatory Agency (ANSM)
• 2019-present: Member of the Pharmacology group of the French National Research Agency on HIV and Hepatitis (ANRS)
• 2019-present: member of national learning societies in transplantation: “Société Francophone de Transplantation” (SFT); “Société Française de Néphrologie, Dialyse et Transplantation” (SFNDT)
• 2018- present: Editor “La lettre de l’infectiologue”, Edimark
• 2017 – 2021: Member of the scientific counsel of the Faculty of Medicine of the Rennes 1 University
• 2014 – present: Member of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), member of the Immunosuppressive drugs (ISD) committee of IATDMCT, Team leader “Intracellular therapeutic drug monitoring” of the ISD committee
• 2010 – present: Member of the national society « Société Française de Pharmacologie et Thérapeutique (SFPT) », Member of the national sub-group society « Groupe de suivi thérapeutique pharmacologique de la SFPT », Team leader « Immunosuppressive drugs »
• 2007/2008: President of the Poitiers Pharmacy Residents Association (AIPP)
• 68 international peer-reviewed articles
• 29 oral communications in scientific conferences
• 11 research grants as principal investigator from 2012 for a total amount of 778,500 euros

Statement of Interest

As a member of the IADTMCT since 2014, I would like further contributing to the learning society by joining its council. The IATDMCT is a wonderful framework for pharmacologists and I will be happy, if my colleagues support my candidacy, to help continuing developing it as secretary of the association.

Employment

• 2018 – Medical Head Therapeutic Drug Monitoring, Synlab Holding Germany GmbH, MVZ Leinfelden-Echterdingen with teaching appointment at University of Tübingen
• 2003 -2018 – Senior scientist and Head TDM/Tox Section, Institute of Clinical Chemistry and Laboratory Medicine, Klinikum Stuttgart, Germany
• 1999- 2002 – Resident Dept. of Clinical Chemistry, University Göttingen, Germany
• 1995-1999 – Postdoctoral fellow, Dept. of Clinical Chemistry, University Göttingen, Germany
• 1992-1995 – Resident Dept. of Clinical Chemistry, University Sofia, Bulgaria
• 1991-1992 – Resident Dept. Internal Medicine, University Sofia, Bulgaria

Education & Certification

Academic Degrees:

• Dr. med. University Göttingen, Germany, 2002
• D-r (BG)., University Sofia, Bulgaria, 1990

Professional Registrations:

• Fellow European Board of Laboratory Medicine/Medical Biopathology (F.E.B.L.M./M.B.), 2013
• Clinical Pathology Consultant, 1996

Professional Activities

Professional Society Memberships:

• Vereinte Deutsche Gesellschaft für Laboratoriumsmedizin und Klinische Chemie (DGKL)
• International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
• Transplantation Society
• Bulgarian Academy of Sciences and Arts

Publications:

• 166 publications contributed to scientific journals and books on the following topics: therapeutic drug monitoring, drug metabolism, drug toxicity, development and evaluation of analytical methods, organ function tests, biomarkers of drug effects

Stipends and Awards:

• 2015 Grant from the Federal Ministry of Education and Research “Validation of GcfDNA based diagnostic test to detect organ damage after kidney transplantation”
• 2011 Grant of the Pathobiochemistry and Molecular Diagnostics Foundation, DGKL, Analytical validation of biomarker assays in transplantation medicine
• 2005 Young Investigator Award of the International Society for Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
• 2004 Grant of the Pathobiochemistry and Molecular Diagnostics Foundation, DGKL, Acyl glucoronides of mycophenolic acid
• 2002 Grant of the University Göttingen, Germany, Acyl glucuronide of mycophenolic acid
• 1998 Stipend Volkswagen Foundation, Germany, Metabolism of immunosuppressants
• 1996 Stipend Otvoreno Obschtestvo, Bulgaria, Pharmacokinetics of Taxol
• 1995 Tempus Phare stipend of the EU, Therapeutic Drug Monitoring

Varia:

• Reviews Editor of Therapeutic Drug Monitoring (TDM) (2018 - )
• Secretary IATDMCT (2017 -2021)
• Director of Education IATDMCT (2015 - 2017)
• Vice-Chair IATDMCT Communication Committee (2011 - 2017) and member of the Communication Committee till 2019
• Member of the IATDMCT Biomarkers in transplantation Working Group (2009 - )
• Coordinator “TDM of Everolimus” Consensus Project (2013-2016)
• Past-Chair of the IATDMCT Immunosuppressive Drugs Scientific Committee (2013–2015)
• Past Editor in Chief of the IATDMCT Newsletter “Compass” (2009 – 2015)
• Member of the LOC of the 11th IATDMCT Congress, 2011, Stuttgart, Germany
• Member of the Editorial Boards of Journal of Laboratory Medicine

Statement of Interest

After 25 years membership in IATDMCT, 8 years in the Communication Committee and 6 years at different positions in the Council I would be honored to bring my experience to the next Council. I am a reliable, responsible person, committed to putting my best in management of the Association matters.

Employment

• Since 2020: Head of Research & Teaching, Pharmacy, member management team Erasmus MC, Rotterdam, The Netherlands
• Since 2017: Associate Professor of Clinical Pharmacometrics, Erasmus MC, The Netherlands
• Since 2011: Supervisor residency Clinical Pharmacology, Erasmus MC, The Netherlands
• Since 2010: Hospital Pharmacist-Clinical Pharmacologist, TDM and Toxicology, Erasmus MC, The Netherlands
• 2009-2010: Residency Clinical Pharmacology, VU University Medical Center, Amsterdam, The Netherlands
• 2006-2009: PhD candidate Nephrology VU, University Medical Center, Amsterdam, The Netherlands
• 2003-2009: Residency Hospital Pharmacy, Meander Medical Center, Amersfoort, The Netherlands

Education & Certification

• Pharmacy University Utrecht, 1996-2003
• BROK, GCP guidelines training
• ISO15189 auditor
• Teaching qualification
• Hospital Pharmacy residency 2003-2009, Meander Medical Center, Amersfoort
• Clinical Pharmacology residency, 2009-2010, VU University Amsterdam

Professional Activities

Publications:

• 136 Peer-reviewed publications (https://pubmed.ncbi.nlm.nih.gov/?term=koch+bc&sort=date)

Activities in IATDMCT:

• Member of the Alternative Sampling Committee
• Member of the Anti-infectives Committee
• Editorial Board Therapeutic Drug Monitoring

Executive Committee:

• EPASG, PK/PD of anti-infectives committee, European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
• Member of SWAB board, Antibiotic Surveillance Working Group, the Netherlands and Guidelines committee
• President Female Academic Network VENA, Rotterdam (2015-2010)
• Board member Dutch knowledge Center Psychiatry and Pregnancy (LKPZ) (2013-2018)

Committees:

• Guidelines committee SWAB
• Member section Clinical Pharmacology Unite Europeene des Medecins Specialistes (UEMS Europe)
• Registration committee Dutch Clinical Pharmacologists (NVKFB)
• Medical Ethical Board Erasmus MC
• Antibiotic committee Erasmus MC
• Registration committee Dutch hospital pharmacists (NVZA SRC)
• National Education program hospital pharmacists (PUOZ), (2011-2016)
• Scientific Board PAO Pharmacy, National Educational Office Pharmacists (2011-2016)
• Member Research Foundation Flanders (FWO), Stategic and Applied Program, Brussels, Belgium

Memberships:

• Member of International Society of Pharmacometrics (ISoP)
• Member of International Society of Anti-infective Pharmacology ( ISAP)
• Member of American Society for Clinical Pharmacology and Therapeutics
• Member of European Association for Clinical Pharmacology and Therapeutics
• Member of ESCMID

Editorial boards:

• Sleep-Wake Research in the Netherlands, 2008-2010
• Current Clinical Pharmacology, since 2017
• Therapeutic Drug Monitoring, since 2020

Professional appointments:

• Psyfar, education company (Prelum) for education in psychopharmacology (2017-2019)
• Advisory Board Pharmacy Universitas Gadjah Mada Indonesia, since 2019
• Scientific committee Universitas Muhammadiyah Yogyakarta, since 2020

Invited talks 2019-2021:

• GGG congress Dolphin studie, Amsterdam 4-4-2019
• NVKF & B 12 april 2019, PK/PD of antibiotics
• IATDM & CT Iguazu (Brasil September 2019): model-based dosing en Antibiotic intensive Care
• Pharmacometrics Meeting Tokyo January 2020
• Online IATDMCT 2020, PK/PD in psychiatry
• Online IATDMCT 2020, Alternative matrices TDM
• Antibiotica bij kids, maart 2021
• EATRIS Health RI, model-based dosing in pediatrics, 2021, digital
• ZonMW GGG congress, Safety and pharmacokinetics of children with autism, 15 april 2021

Employment

• Senior Specialist, Clinical Microbiology and Infectious Diseases
  Clinical lead, anti-infectives therapeutic drug monitoring group
  St. Vincent’s Hospital, Sydney, Australia
• Visiting Medical Officer, St. Vincent's Private Hospital, Sydney
• Visiting Medical Officer, Sacred Heart Hospice, Sydney
• Conjoint Professor, School of Medicine, University of New South Wales
• Adjunct Professor, Faculty of Science, University of Technology, Sydney

Education & Certification

• Fellow of the Royal College of Pathologists of Australasia
• Fellow of the Royal Australasian College of Physicians
• Bachelor of Medicine and Bachelor of Surgery, Honours Class I
• Bachelor of Science (Medicine), Honours Class I

Professional Activities

• Founding member and Past President of the Australasian Society for HIV Medicine
• Past President, Transplant Infectious Diseases (a section of The Transplant Society)
• International Councillor, International Association of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT) 2017-2019
• Director of Education IATDMCT 2019-
• Co-chair of the Anti-Infectives group IATDMCT 2016-
• Over 200 publications in refereed journals
• Reviewer for over 12 journals
• Associate editor, Transplantation

Professional Societies:

• Royal Australasian College of Physicians
• Royal College of Pathologists of Australasia
• International Association for Therapeutic Drug Monitoring and Clinical Toxicology
• Australasian Society for Infectious Diseases
• Australasian Society for HIV Medicine
• Australasian Society for Antimicrobials
• International Immuno-compromised Host Society
• International Society for Heart and Lung transplantation
• Transplant Infectious Diseases
• The Transplant Society
• Australasian Society for Clinical Pharmacology and Toxicology
• Animal Management in Remote and Indigenous Communities
   
• 1986- Member, Drug and Therapeutics Committee, St. Vincent's Hospital
• 1988- Accreditor, National Association of Testing Authorities
• 1989-97 Member, N.S.W. State Committee, Royal Australasian College of Physicians
• 1990- Examiner, Royal Australasian College of Pathologists
• 1993-2014 Member, Tuberculosis Advisory Committee, N.S.W. Department of Health
• 1995 Visiting lecturer, University Santo Tomas, Manila, Philippines
• 1997-99 President, Australasian Society for HIV Medicine
• 2000-10 Member, Pharmacology and Toxicology Working Group, National Centre in HIV Epidemiology and Clinical Research
• 2009-13 Co-chair, Australian and New Zealand Mycoses Interest Group
• 2010- Examiner, Royal Australasian College of Physicians
• 2012- Scientific Committee member (HIV and Infectious Diseases), International Association for Therapeutic Drug Monitoring and Clinical Toxicology
• 2012- Scientific Committee member, International Society for Heart and Lung Transplantation
• 2012- Scientific Committee member, Transplant Infectious Diseases
• 2013- President, Transplant Infectious Diseases
• 2013- Board Member, Medical Advances without Animals
• 2014- Visiting Lecturer, The Academy of Medicine, Singapore
• 2014- Visiting International Professor, Royal College of Pathologists of Australasia
• 2014- Member, ESPAG group, ECCMID
   
• Proposer and Co-Convener – joint IATDMCT/TID/The Transplant Society (TTS) Conference, Hong Kong, 2016 in conjunction with TTS Conference
• Keynote and invited speaker at many national and international meetings including ICAAC (Denver 2012), ISHLT (Montreal, 2012; San Diego, 2013), The World Transplant Congress (San Francisco 2014), Transplant Infectious Diseases (Berlin, 2012; Vienna, 2013; Barcelona 2014), ISHAM (Melbourne 2015), Transplant Infectious Diseases (2014, 2015, 2016), IATDMCT (Salt Lake City, 2012, Rotterdam, 2016, Kyoto 2017, Brisbane 2018, Iguassu 2019, Virtual ‘Banff’ meeting 2020))
• Convener and speaker at a number of regional Mycology Master Classes run under the auspices of the International Society of Human and Animal Mycology (ISHAM) including Phuket (2011), Singapore (2012), Seoul (2013) and Penang (2014) and Bangkok (2016)
• Coordinator of the Clinical Stream at the ISHAM conference in Melbourne (May 2015) and convener of the pre-congress workshop on Therapeutic Drug Monitoring in Fungal Infections
• Invited speaker, 5th Annual National conference on Therapeutic Drug Monitoring and First Asia-Pacific Symposium on Therapeutic Drug Monitoring. Beijing, September 2015 and 6th Annual National Congress on Therapeutic Drug Monitoring. Nanjing, China. September 2016
• Invited speaker and representative of IATDMCT with multiple presentations. The National Symposium on Therapeutic Drug Monitoring, Vellore, India, July 2017
• Congress organizing committee, member of the scientific committee and invited speaker. 16th IATDMCT, Brisbane, Australia. September 2018
• Invited speaker, 10th National Annual Conference of TDM-China. September 2020
• Convener and organizer, first Asia-Pacific TDM workshop to be held under the auspices of IATDMCT in conjunction with the Asia Pacific Conference on Clinical Microbiology and Infection. November 2020 (postponed due to COVID-19)
• Convener and organizer, Asia – Pacific TDM meeting (virtual) – October 2021
• Convener and organizer, South American Anti-Infective TDM workshop (virtual) – March 2022
• Extensive connections with the Asian region and an invited speaker at many conferences within Asia, including Malaysia, Hong Kong, Singapore, Indonesia, India, Japan and China
• Reviewer of approximately 15 manuscripts per year for the past 10 years in local and international journals

Employment

• Chair of Experimental and Clinical Toxicology, Saarland University, Homburg, Germany
• Clinical Pharmacology Heidelberg University Hospital, Heidelberg, Germany
• Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden

Education & Certification

• Habilitation with Venia Legendi for Pharmacology & Toxicology
• PhD
• M.Sc., Pharmacist
• Clinical toxicologist certified by GTFCh

Professional Activities

• Memberships in IADTMCT, TIAFT, GTFCh (German speaking society of forensic chemistry), DPhG (German society of pharmaceutical sciences), DGPT (German speaking society of pharmacology and toxicology), DGMS (German speaking society of mass spectrometry)
• Activities in IATDMCT: since 2019 Director of Education, until 2019 Vice chair young scientist committee, until 2019 Member of communication committee
• Executive and committee positions held: TIAFT (Young scientist committee member), GTFCh (Chair of the continuous education program), IATDMCT (Councilor)
• Number of publications: over 180 PubMed-listed and peer-reviewed articles, numerous book chapters
• Speaking engagements: Several invited talks at international conferences (USA, Europe, Asia)
• Professional appointments: Clinical toxicologist GTFCh

Employment

• 2017 – to date, Clinical Pharmacologist, National Center of Hepatobiliopancreatic Treatment, Teaching & Care, Uruguay.
• 2013 – to date, Clinical Pharmacologist and Researcher, National Center for Liver Transplantation and Liver Diseases, Army Forces Hospital, Ministry of Defense, Uruguay.
• 2006 – 2013, Logistics & Supply Chain Head, National Directorate of Peripheral Health Care, National Directorate of Army Forces Health Care, Ministry of defense, Uruguay.
• 2005 – 2006, Quality Assurance Coordinator, Pharmaceutical Laboratory, National Directorate of Army Forces Health Care, Ministry of Defense, Uruguay.
• 1999 – 2006, Environmental, Occupational Health and Safety Coordinator, Colgate Palmolive, Uruguay.
• 1997 – 1997, Sterile Dosage Forms Supervisor, Urufarma (Bristol Myers Squibb Co.), Uruguay.
• 1991 - 1997: Manufacturing Supervisor, Ciba Geigy / Novartis, Uruguay.
• 1988 - 1991: Quality Control Laboratory Analyst, Boehringer Ingelheim, Uruguay.

Education & Certification

• PhD Biology and Health Sciences, Limoges University, France, 2015.
• PhD Chemistry, Universidad de la República, Uruguay, 2015.
• Diploma Hospital Pharmacy Specialist, Universidad de la República, Uruguay, 2010.
• MSc Clinical Pharmacology, Universidad de Montevideo, Uruguay, 2010.
• Pharmacist & Chemist Doctor, Universidad de la República, Uruguay, 1999.

Professional Activities

Professional Society Memberships:

• 2021 International Society for Advancement of Cytometry
• 2019 – to date, Organization for Women in Science for the Developing World
• 2010 – to date, International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
• 2017 – 2019, American Society of Transplantation
• 2015 – to date, International Liver Transplantation Society
• 2000 – 2012, International Pharmaceutical Federation
• 1999 – to date, Uruguayan Association of Chemistry & Pharmacy

IATDMCT:

• 2018 - 2021, Communications Committee Vice-Chair
• 2020 - to date, Communications Committee Webmaster CoManager
• 2016 - to date, Communications Committee and Linkedin Manager
• 2011 - to date, Biomarkers in Transplantation Working Group
• 2011 - to date, Immunosuppressive Drug Committee

Organization for Women in Science for the Developing World:

• 2021 – Relationships with Uruguayan Diaspora Committee
• 2021 -, Professional Development Committee

International Liver Transplantation Society:

• 2021 - , Cardiovascular and Infectious Disease Committees
• 2016, Coordinator of the II Latin American Liver Transplantation Meeting

American Society of Transplantation:

• 2018 – 2019, Adherence Working Group
• 2017 – 2019, Community of Practice for Transplant Pharmacists

Uruguayan Association of Chemistry & Pharmacy:

• 2004 – 2006, Vice - Chair
• 2002 – 2006, Board Member
• 2001 – 2004, Academic Courses Coordinator

Publications:

• 10 Contributions to scientific journals and book chapters on the following topics: therapeutic drug monitoring, biomarkers in solid transplantation, machine learning, analytical methods, and antibiotics.
• Reviewer of approximately 5 manuscripts per year for the past 3 years in refereed international journals.

Research Areas:

• TDM, biomarkers in solid transplantation, PK/PD/PG relationships, cell signaling, machine learning, metabolomics, hepatitis C virus, liver fibrosis, patient adherence.

Employment

• 1999-2004: PhD in Medical Sciences (performed @ Faculty of Medical Sciences at Ghent University)
• 2004-2007: Postdoc @ Faculty of Sciences (VIB - Ghent University)
• 2007-Jan 2013: Postdoc @ Faculty of Pharmaceutical Sciences (Lab of Toxicology, Ghent University)
• Feb 2013-Jan 2018: Assistant-Professor (“Docent tenure-track”) (Lab of Toxicology, Ghent University)
• Feb 2018-now: Associate Professor (“Hoofddocent”) (Lab of Toxicology, Ghent University)

Education & Certification

• 1999: Pharmacist (Ghent University)
• 2004: PhD in Medical Sciences (performed @ Faculty of Medical Sciences at Ghent University)
• Recognized by the Department of Justice as expert for determination of alcohol in cases of drunk driving (since Sept 4, 2014) and for expert advice in cases involving toxicological expertise
• Director of the ISO 17025/1595 accredited Reference Laboratory Ref4U, implementing reference measurement procedures for e.g. thyroid hormones and vitamin D

Professional Activities

Teaching activities
Responsible for the following courses:

• General Toxicology (3rd Bachelor)
• Bioanalysis (Master)
• Chemical Criminalistics (Master)
• Drug Toxicity (Master)
• Supplements in Toxicology: advanced studies (MaNaMa Clinical Biology)
• Co-responsible for Bioanalytical Practical Course

Research activities (overview & selection):

• Publications (also see links: Google Scholar; Pubmed; http://orcid.org/0000-0001-7126-348X) General Overview (based on Web of Science ranking 2019):
• >160 peer-reviewed scientific publications
  • >30% of all publications is in top 10% journals;
  • >60% of all publications is in Q1 journals;
  • >95% of all publications is in Q1 & Q2 journals;
  • On ~2/3 of all publications, C. Stove is first author or lead/corresponding author.
• H-index of 32 (Web of Science) – 39 (Google Scholar)
• Citations: >3000 (Web of Science) - >4500 (Google Scholar)
• Acquisition of competitive research funding: ~1.75M€ projects + ~50 person-years (PhD students & postdoc)
• Promotor of 15 defended PhDs and 8 ongoing PhDs
• 3 main research lines can be distinguished:
  • Alternative sampling strategies (e.g. dried blood microsampling, hair analysis)
  • Development of bio-assays for monitoring of activation of G-protein coupled receptors
  • Analysis of vitamers (amongst which folates and thiamins), their precursors and degradation products, in plant material and biological material (blood)
• Editorial Board Member of Clinical Biochemistry (Associate Editor), Journal of Analytical Toxicology, Therapeutic Drug Monitoring
• Guest Editor for Special Issues of the peer-reviewed journals Bioanalysis, Forensic Science International, Frontiers in Chemistry, Journal of Analytical Toxicology, Therapeutic Drug Monitoring
• Peer review: from 2016 to now: over 380 peer reviews, for over 60 scientific journals. Journals for which ≥20 reviews were performed during the past 5 years: Analytical Chemistry, Analytical and Bioanalytical Chemistry, Bioanalysis, Clinical Biochemistry, Forensic Science International, Journal of Chromatography B, Journal of Pharmaceutical and Biomedical Analysis, Therapeutic Drug Monitoring
• Involved in the organization of international scientific congresses (TIAFT, IATDMCT, EBF, CPSA, MSACL), as part of the scientific committee; main organizer of the annual TIAFT conference in Ghent, in 2018 (~700 attendants)
• >200 oral and poster presentations at national and international conferences (many on invitation)

Member of scientific societies:

• Toxicological Society of Belgium and Luxemburg (BLT) (Board Member)
• Belgian Environmental Mutagen Society (BEMS) (Board Member)
• The International Association of Forensic Toxicologists (TIAFT) (Board Member)
• International Association for Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) (Council Member – 2 terms); Former chair & vice-chair of the Alternative Sampling Strategies Committee
• Belgisch Genootschap voor Gerechtelijke Geneeskunde (BGGG) (Board Member)
• Part of national (BOF & FWO (Med1)) and international (UK, The Netherlands, France, Switzerland, Czech Republic) project assessment committees
• External assessor of applications for academic positions (several universities in the UK)
• Member of >60 PhD Evaluation committees (UGent (primarily Fac. Pharmaceutical Sciences, but also Fac. Sciences & Fac. Medicine & Health Sciences), KULeuven, UK, Australia, The Netherlands, Denmark)
• Granted patent: Dried blood sample analysis: granted patents: EP3359950A1 (EU) and US10222324 (US) (hyperlink). This has also led to commercialization (by CAMAG, Basel, Switzerland)

Service Activities (external):

• Head of the Laboratory of Forensic Toxicology, follow-up of routine casework in judicial cases since Jan 1st 2008; end responsible (lab director) since Sept 15, 2014. Provided many hundreds of reports to the Department of Justice since then.
• Core member of the Forensic Institute of Ghent University (FI-UGent).
• Toxicological consultancy; ad hoc toxicological expertise (e.g. Superior Health Council, Fonds Medische Ongevallen, FAGG – Committee on Herbal Medicinal Products for Human Use).
• Provision of toxicological expertise in the train disaster at Wetteren (05/2013 - on-site expertise, scientific publications, part of the Superior Health Council, report to fed. Min. of public health, …).
• Recognized by the Department of Justice as expert for determination of alcohol in cases of drunk driving (since Sept 4, 2014) and for expert advice in cases involving toxicological expertise.
• Director of the ISO 17025/1595 accredited Reference Laboratory Ref4U, implementing reference measurement procedures for e.g. thyroid hormones and vitamin D.

Employment

• University of Utah
  • Pathology (Clinical Pathology), 03/01/2009 - Present
  • 03/01/2009 - 12/31/2009 – Visiting Instructor
  • 01/01/2010-06/30/2016 – Assistant Professor (Clinical)
  • 07/01/2016-Present – Associate Professor (Clinical)

Education & Certification

• 2006 - 2009 – Fellow – University of Utah, Department of Pathology (Clinical Chemistry), Salt Lake City, Utah
• 2004 - 2006 – Postdoctoral Fellow – University of Utah, Center for Human Toxicology, Research Associate (Human Toxicology), Salt Lake City, Utah
• 1999 - 2004 – Ph.D. – University of Utah, Department of Pharmacology &Toxicology (Pharmacology), Salt Lake City, Utah
• 1994 - 1999 – B.S. – University of California, Riverside, Department of Biochemistry (Biochemistry), Riverside, California

Professional Activities

Current Memberships in Professional Societies:

• AACC Academy
• Academy of Clinical Laboratory Physicians and Scientists
• American Association for Clinical Chemistry
• International Association of Therapeutic Drug Monitoring and Clinical Toxicology
• Society of Forensic Toxicologists

Administrative Experience:

• 2019 - Present – American Association for Clinical Chemistry, Lab Tests Online, website reviewer
• 2019 - Present – American Association for Clinical Chemistry, Publications Core Committee Member
• 2019 - Present – American Association for Clinical Chemistry, TDM Toxicology Committee, Treasurer
• 2018 - 2019 – American Association for Clinical Chemistry, Mass Spectrometry Separation Science Committee, Secretary
• 2018 - 2019 – Professional Practice in Clinical Chemistry, Organizing Committee Member
• 2017 - 2019 – Resident In-Service Examination (RISE) Committee Member, Specialty: Chemistry, American Society for Clinical Pathology. Chair – Jonathan Genzen, MD, PhD

Activities in IATDMCT:

• 2018 - Present – Chair, Communications Committee, International Association of Therapeutic Drug Monitoring and Clinical Toxicology - compile communication information from the IATDMCT executive committee for dissemination to the membership
• 2018 - Present – Committee Member, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Immunosuppressive Drug Committee
• 2013 - 2018 – Member, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Young Scientist Committee
• 2013 - Present – Committee Member, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Clinical Toxicology and Drugs of Abuse Committee

Publications:

• 55 peer-reviewed published manuscripts
• 15 published book chapters

Speaking Engagements:

• >30 Oral presentations and National/International Conferences

Professional Appointments:

• 2020 – 2025 – Commissioner, Commission on Accreditation in Clinical Chemistry (ComACC)
• 2019 - Present – Clinical Chemistry Fellowship Program, Director Department of Pathology, University of Utah, Salt Lake City, UT

Employment

• 2021- – Associate Professor, Osaka Medical and Pharmaceutical University (University name was changed)
• 2018-2021 – Associate Professor, Osaka University of Pharmaceutical Sciences
• 2016-2017 – Visiting Professor, University of Toronto
• 2012-2015 – Lecturer, Osaka University of Pharmaceutical Sciences
• 2005-2011 – Assistant Professor, Osaka University of Pharmaceutical Sciences
• 2002-2005 – Hospital Pharmacist, Yokkaichi Social Insurance Hospital

Education & Certification

• 1996-2000 – Faculty of Pharmacy, Kanazawa University (BS)
• 2000-2002 – Faculty of Pharmacy, Osaka University (MS)
• 2008 – Osaka University of Pharmaceutical Sciences (PhD)

Professional Activities

• 2000- – Member, Japanese Society of Pharmaceutical Health Care and Sciences
• 2001- – Member, Japanese Society of Therapeutic Drug Monitoring (JSTDM)
• 2001- – Member, Japanese Society for the Study of Xenobiotics
• 2005- – Member, Pharmaceutical Society of Japan
• 2005- – Member, Japan Society of Circulation Control in Medicine
• 2009- – Member, International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
• 2010- – Member, Japanese Society of Pharmaceutical Palliative Care and Sciences
• 2011- – Member, Japanese Society of Clinical Pharmacology and Therapeutics
• 2011-2015 – Young Scientist Committee Member, IATDMCT
• 2012- – Member, Japanese Society of Toxicology
• 2012- – Member, Japanese Society of Nephrology and Pharmacotherapy (JSNP)
• 2012- – Editorial Board Member, JSNP
• 2014-2017 – Chair of Young Scientist Committee, JSTDM
• 2014- – Councilor, JSTDM
• 2015- – Communication Committee Member, IATDMCT (2021- Vice Chair)
• 2015- – International Exchange Committee Member, JSTDM (2020- Chair)
• 2015- – International Exchange Committee Member, JSNP
• 2016- – Member, Society of Toxicology
• 2017-2020 – Inspector, JSTDM
• 2019- – IATDMCT, Councillor
• 2020- – Director, JSTDM
• 2020- – Chair of Academic Committee, JSTDM
   
• I am author or co-author of more than 70 peer-reviewed manuscripts.

Employment

• 2019 - – Professor of Pediatrics, Clinical Scholar, Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
• 2013 – 2018 – Associate Professor of Pediatrics, Clinical Scholar, Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
• 2002 – 2013 – Assistant Clinical Professor of Pediatrics, Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, CA, USA

Education & Certification

• 1991 – B.A. (Highest Distinction honors), Molecular and Cell Biology (Neurobiology) University of California at Berkeley, Berkeley, CA
• 1996 – M.D., University of California at Davis, Davis, CA

Post-Graduate Training:

• 1996 – 1999 – Internship and Residency, Pediatrics, Rainbow Babies and Children’s Hospital, University Hospitals of Cleveland, Cleveland, OH
• 1999 – 2002 – Fellowship, Pediatric Infectious Diseases, Fellowship, Pediatric Clinical Pharmacology, Rainbow Babies and Children’s Hospital, University Hospitals of Cleveland, Cleveland, OH
• 2011 – Master’s Degree in Clinical and Biomedical Investigations, University of Southern California, Los Angeles, CA

Professional Activities

Publications:

• 149 peer reviewed manuscripts
• One textbook - Individualized Drug Therapy for Patients: Basic Foundations, Relevant Software and Clinical Applications 1st Edition, 2016. Editors: Jelliffe RW, Neely MN.
• 9 book chapters

Speaking engagements:

• Over 100, including more than 40 international invitations

IATDMCT:

• Member since 2011
• Attendee at every congress since joining
• Councilor 2017-2019
• Member Anti-Infective Scientific Committee and Pharmacometric Committee
• Former Vice-chair and Chair of Anti-Infective Scientific Committee
• Congress Scientific Committee Member IATDMCT Rome 2021 and Iguacu 2019
• Recipient 2017 Patzalos Prize

American College of Clinical Pharmacology:

• Fellow since 2011
• Regent 2015-2020
• Roger Jelliffe Award in Individualized Therapy 2020
• Excellence in Achievement 2021

Employment

• July2017-to date – Additional Professor, Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
• July2014-June2017 – Associate Professor, Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
• Apr2011-July2014 – Assistant Professor, Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
• Oct 2010- Apr 2011 – Assistant Professor, Pharmacology, Government Medical College and Hospital Sector-32, Chandigarh, India
• Jul 2009- Oct 2010 – Senior research Associate in Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
• Jul 2006- Jun 2009 – Senior Resident (DM) Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
• Jan 2006- Jun 2006 – Senior Resident (Non-DM) Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
• Jul 2002- Dec 2005 – Junior Resident Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
• Nov 1999- Oct 2000 – Intern (compulsory rotatory internship program during MBBS), Sriram Chandra Bhanja Medical College and Hospital Cuttack, Orissa, India

Education & Certification

• Dec 2014-Aug 2015 – Fulbright-Nehru Academic and Professional Excellence Fellowship, Emory Clinical and Translational Research Laboratory, Emory University School of Medicine, Atlanta, GA, USA. Sponsored by The Council of International Exchange of Scholars and United States India Education Foundation
• July 2013- June 2014 – Global Clinical. Scholars Research and Training Program, Harvard Medical School, Boston, MA, USA
• July 2006- June 2009 – Doctorate of Medicine (DM), Clinical Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
• June 2006 – Diplomate of National Board (DNB), Pharmacology, National Board of Examination, New Delhi, India
• July 2002-Dec 2005 – Doctor of Medicine (MD), Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
• Sept 1994-Oct 2000 – Bachelor of Medicine and Bachelor of Surgery (MBBS), Shriram Chandra Bhanja Medical College and Hospital, Cuttack, Odisha, India

Professional Activities

Affiliation and membership of professional societies:

• Life member of Indian Pharmacological Society (IPS)
• Member of Indian Society of Rational Pharmacotherapeutics (ISRPT)
• Member National Academy of Medical Sciences (MNAMS)
• Member International Medical sciences Academy (IMSA)
• Indian Society of Organ Transplantation (ISOT)
• Member of British Pharmacological Society (BPS)
• Member of American College of Clinical Pharmacology (ACCP)
• Member of International Association of Therapeutic Drug Monitoring and Toxicology (IATDMCT) Immunosuppressive Drugs Committee

Activities within IATDMCT:

I joined IATDMCT as a young scientist in 2012 and have been a member from a developing country since 2012. My Fulbright Nehru Fellowship mentor Prof. Ritchie James from Emory University Medical School Atlanta USA did receive my request though IATDMCT circle and it had been a very successful professional journey for me so far. I have learned the nuances of TDM of ISDs from his laboratory and now employing them to our setting in India. IATDMCT has helped me immensely to grow as a researcher and keeping abreast with the world. I have been able to attend the congresses at Rotterdam, Kyoto and Iguazu. I was invited to represent India and deliver a talk on “ TDM in India’ in the symposium -TDM in Asia, at the Kyoto congress. My close interaction with the experienced researchers has always been very rewarding. By sharing the clinical problems in our setting regarding the ISD use, many new research ideas come up to address those questions and the prospect of collaborative research. We have been using the online platform of the University of Limoges for our ISD dose adjustment of our patients. We have also been able to organize a workshop at New Delhi, India in October 2019 entitled “Therapeutic Drug Monitoring of Immunosuppressants: Clinical Challenges and Analytical Issues” at the Asian Society of Transplantation meeting with help of Prof. Amitava Dasgupta of the University of Texas McGovern Medical School, Huston, USA. Dr Dasgupta also visited our center as a guest faculty to. Deliver a lecture and to interact with the. Faculty and. The students. I have been a member of the ISD committee for the past one year and attending the activities of the society. Overall, I have been able to start my research journey with the society and it has caught some momentum thus far, I would be glad to give back by facilitating others in their endeavors.

Reviewer of scientific journals and Editorial board member:

• British Journal of Clinical Pharmacology
• Journal of Cardiovascular Drugs and Therapy
• Journal of Pharmacology and Pharmacotherapeutics
• International Journal of Basic and Applied Medical Research
• Indian Journal of Urology
• Toxicology and Industrial Health
• Editorial board member
  • International Editorial Board (2016-2021)

Awards and Honours:

• Honored as an invited Alumni to the panel discussion (virtual mode) in the eighth ‘Global Clinical Scholars Research Training program 2020-21’ on 4th Dec 2020 hosted by the Harvard Medical School Boston, United States of America.
• Awarded the Paul Dudley White International Scholar award as a recognition for the authors with the highest ranked abstract from India at the International Stroke Conference of the American Heart Association at Los Angeles, USA on 20th May 2020.
• Awarded the Best Paper-First Prize of the Indian Journal of Urology for the year 2019 for the paper Indian J Urol. 2019;35:25-33 and a plaque to honor this achievement at the Annual meeting of Urological Society of India USICON 2020 at Kochi.
• Awarded the Best researcher in the category of Additional Professors in the 7th Annual Institute Research Day, for publishing high quality research in the Institute Research Appreciation Program on PGIMER Annual Research Day on 5th October 2019.
• Awarded with travel grant and invited as a speaker to talk on “TDM in India” in the symposium “TDM is Asia” to the World congress of Therapeutic Drug Monitoring and Clinical Toxicology held at Kyoto, Japan 23rd-27th Sept 2017.
• Serving on the board of International Editors of the British Journal of Clinical Pharmacology of the British Pharmacological Society for a period of 5 years (August 2016 to July 2021).
• ‘Eagle Eye Award’ from the Editors of Goodman and Gillman Pharmacological Basis of Therapeutics; June 2016.
• Awarded the Fulbright-Nehru Academic and Professional Excellence Fellowship for 2014-2015, under the mentorship of Prof. James C Ritchie, Emory Clinical and Translational Research Laboratory of the Emory University School of Medicine and Emory University. Could be found at ( http://www.usief.org.in/INF-2014-15/Academic-and-Professional-Excellence-Scholars/Smita-Pattanaik.html).
• Awarded Full Scholarship for the ‘Global Clinical Scholars Research Training program 2013-14’ by the Harvard Medical School Boston, United States of America. Could be found at (http://hms.harvard.edu/departments/global-clinical-scholars-research-training-program/gcsrt-program-scholarships).
• Awarded Distinction for the CAPSTONE proposal in the ‘Global Clinical Scholars Research Training program 2013-14’ by the Harvard Medical School Boston, United States of America.
• Awarded the Best researcher in the category of Assistant Professors in the second Institute foundation day Research Appreciation Program in 2013.
• Best Outgoing Student of the district and 23rd best student in Orissa in the State Senior Secondary School Examination batch of 1991.

Publications:

• 35 journal articles
• 16 abstracts
• 5 book chapters
• 1 book as editor

Invited Lectures:
International:

• Invited lecture at the 15th IATDMCT World Congress at Kyoto for the Symposium on ‘TDM in Asia’ – on 25th October 2017 to deliver a lecture on ‘TDM in India’
• Invited to ‘Special Challenges of the Therapeutic Drug Monitoring of Immunosuppressant Drugs in the Indian subcontinent’ at the 16th Congress of the Asian Society of Transplantation (CAST-2019) and the joint meeting of 30th Annual Conference of Indian Society of Organ Transplantation (ISOT), New Delhi India from 29th of September to 2nd of October 2019.
• Invited as an Alumnus to the panel discussion (virtual mode) of the eighth ‘Global Clinical Scholars Research Training program 2020-21’ to share the experience on 4th Dec 2020 hosted by the Harvard Medical School Boston, United States of America.

National:

• RCT: Superiority, Non-inferiority and Equivalence Trials”. (sponsored by the organisers). Third International Conference on Evidence-Based Medicine & Clinical Research (EBCCON) 7-8th Feb 2020 held at SRM Medical College in Chennai
• “Understanding Type, Level, Strength and Grade of Evidence”. Lecture in the symposium entitled “Rational Prescribing” on 30th November 2019 at the ISRPTCON 2019 at the Science City Auditorium, Kolkata
• "Randomized Clinical Trials" and "Bias in clinical research" (sponsored by the organisers). The 2nd National workshop on Bio-statistics and Clinical Research Methods (NCRM-2019) held at SRM Medical College, Chennai
• Engaging Patients to Ensure Patient Safety, Theme Drug: Tacrolimus, Theme Disease: Renal Transplantation (Participation in virtual mode). First conference on Patient Safety at Kolkata on September 17th 2019
• Invited as a visiting faculty by Dr Mohan M Rajapurkar, President of the Indian Society of Nephrology and Director, Post-Graduate Studies & Research, Muljibhai Patel Urological Hospital Nadiad, Gujrat (6th-7th April 2019) to set-up the TDM centre for the immunosuppressant drugs post renal transplantation
• “Prescribing Training Skills in India: A Situation Analysis “. Resource Person for the pre-conference workshop on Development of Modules for Prescribing Skills and delivered the lecture on 23rd Nov2018
• “Rational Prescribing”. a lecture in the symposium entitled on 30th November 2019 at the ISRPTCON 2019 at the Science City Auditorium, Kolkata
• "Artificial Intelligence in Clinical Research" a resource person for the pre-con symposium on clinical pharmacology Hands-on exercises for MD students. 28th Annual Conference of Indian Pharmacological Society, West Bengal and Transmed 2019) held on 22nd and 123rd February, 2019 at Burdwan, West Bengal
• “Artificial Intelligence in Clinical Research”. 10th Annual National conference of the Indian Society for Rational Pharmacotherapeutics held at IGIMS-Patna from 24th-25th Nov 2018
• “Therapeutic Drug Monitoring and Pharmacogenomics”. 29th Annual conference of Indian society of Organ Transplantation at Hyderabad (05th-07th Oct 2018) on 5th October 2018
• Therapeutic Drug Monitoring – Utility, Challenges and Limitations" 35th Nati Symposium "Pharmacotherapy – Optimizing Patient Outcome". 27th Annual Conference of Indian Pharmacological Society, West Bengal & Eastern Regional Colloquium (IPSWBCon2017)
• Invited as a speaker and resource person for the National workshop on outcome research methods held at Calcutta School of Tropical Medicine at Kolkata 25-28th May 2017. Delivered the talk entitled: Systematic Reviews: My experience with the Cochrane Collaboration
• Invited as a speaker to Invited as a speaker to 50th Annual Conference of the Indian Pharmacological Society - 2015 (AIGJCONIPS-2017)” at the Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna from 13th to 15th Feb 2017
  (i) and delivered a talk “setting up a TDM Lab/Service
  (ii) delivered talk on Drug analysis in body fluids – Process Validation and impact on TDM
• Invited lecture at SCB medical college and hospital on 12 th June 2016, systematic review and meta-analysis: the feasible original research in our setting
• Invited as a speaker to 7th National conference of Indian Society for Rational Pharmacotherapeutics - 2015 (ISRPTCON-2015)” in PGIMER Chandigarh from 4th to 6th December and delivered a talk “Therapeutic Drug Development: Why we are still a developing country” on 06 December, 2015

Current Job profile and Research Interests:

As an Additional Professor of Clinical Pharmacology, I am involved in training program of the MD, MSc, (Pharmacology) and DM (Clinical Pharmacology) students that is in form of seminars, journal clubs, practical classes, and periodic assessments. It provides me an opportunity to get engaged in regular academic discussions on Clinical Research Methodology, Biostatistics, and research data analysis, which are of great interest to me since my student days. I am involved in planning and executing research projects in form of thesis or dissertation of our students and co-supervising students from other clinical departments. Currently I am executing my research work with the help of my doctoral students (5), research fellow (1) and residents (1). We have some ongoing investigator-initiated studies funded by our institute and extramural funding agencies (as mentioned above). Our group focuses on the translational research involving immunosuppressant drugs (ISDs), repositioning of drugs as anticancer agents and collaborative clinical trials. Our department provides Therapeutic Drug Management (TDM) services for Lithium, Phenytoin, Carbamazepine, Phenobarbitone which I oversee. TDM of (ISDs) and research their dose individualization is the need of the hour. I am involved in the TDM of ISD, in collaboration with the Paediatric Biochemistry department and most of the current projects are in kidney transplantation. The scope of modernizing our patient care through TDM, model informed precision dosing and pharmacogenomics guided dosing is immense, and it is my firm conviction that it would certainly make a difference for our patients. At this point of my career, I intend to concentrate on developing an ‘integrated patient care and research’ model at our center.

• Clinical Pharmacology of Immunosuppressant drugs
• Therapeutic drug Monitoring, Model Informed Precision Dosing and Pharmacogenomics
• Clinical Research Methodology and Biostatistics
• Clinical Pharmacology of drugs acting on genitourinary system
• Drug repositioning in cancer chemotherapy

Employment

• Head of Clinical Trials, Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden 01-SEP-2017 to present (includes managing both the Clinical Pharmacology Trial Unit and the Residents and junior doctors in Clinical Pharmacology)
• Head of the Clinical Pharmacology Trial Unit, Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden, 01-OCT-2013 to 30-AUG-2017
• Head of Residents and Director of Education in Clinical Pharmacology at Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden, 01-DEC-2010 to 30-SEP-2013

Education & Certification

• Medical doctor, Karolinska Institutet, 19-JAN-1996
• Specialist in Renal medicine, 31-MAY-2003
• Specialist in Clinical Pharmacology, 19-DEC-2007
• Swedish Diploma in Clinical Trials, 06-JUN-2016

Professional Activities

• Scientific Secretary of the Swedish Foundation for Clinical Pharmacology and Pharmacotherapy since 2015
• Swedish national representative in the UEMS Section for Pharmacology since 2016
• Director of Education for IATDMCT since 2017
• Member of the Editorial Board of Therapeutic Drug Monitoring since 2019
• More than 500 teaching hours for students in medicine, biomedical science, pharmacy, nursing and for postgraduate professionals (nephropharmacology, immunosuppressants, clinical pharmacology, general pharmacotherapy, clinical pharmacokinetics etc.)
• 42 publications on Publons.com, 445 citations, h-index 12 (as of 28-MAY-2021)

Employment

• Since 2013 – Researcher, HEDEX research group (Health - Endocrine Disruptors – Exposome), Clinical Investigation Center (CIC 1402) INSERM (National Institute of Health and Medical Research), University hospital, Poitiers, France.
• 2002 - 2009 – Researcher, Pharmacology of antimicrobial agents, Inserm U1070, University of Poitiers, France.
• 2003 - 2014 – Head of Pharmacokinetics Unit, Toxicology and Pharmacokinetics department, University hospital, Poitiers, France.
• Since 1999 – Hospital Practitioner specialized in Therapeutic Drug Monitoring and Clinical Toxicology, Toxicology and Pharmacokinetics department, University hospital, Poitiers, France.

Education & Certification

• 2018 – Accreditation to supervise research, Specialty Medicine (Habilitation à Diriger les Recherches, HDR), Faculty of Medicine and Pharmacy, University of Poitiers, France
• Since 2017 – Expert in Pharmacology and Toxicology at the Court of Appeal of Poitiers
• 2008 – PhD in Pharmaceutical Sciences, Faculty of Medicine and Pharmacy, University of Poitiers, France
• 2002 – Master of Science, Faculty of Pharmacy, University of Tours and University of Paris, France
• Since 1999 – Registered to the French National Order of Pharmacists (Ordre National des Pharmaciens , Biologie Medicale)
• 1999 – Post-Graduate Specialist Diploma, Faculty of Pharmacy, University of Bordeaux 2, France
• 1999 – PharmD, Faculty of Pharmacy, University of Bordeaux 2, France

Professional Activities

Activities in IATDMCT:

• Since 2019 – IATDMCT Council, Councillor (elected) for the period 2019-2021
• Since 2017 – Chair of the Toxicology and Environmental Health scientific committee at IATDMCT
• Since 2017 – Organizer of symposiums at the Kyoto, Brisbane, Foz do Iguaçu IATDMCT meetings and for the 2020 virtual meeting
• 2017 – Launch of the new scientific committee dedicated to Toxicology and Environmental Health at IATDMCT
• Since 2006 – Member of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)

Other memberships:

• Since 2003 – Member of the French Society of Pharmacology and Therapeutics (Societe Française de Pharmacologie et Therapeutique)
• Since 2003 – Member of Therapeutic Drug Monitoring subgroup from the French Society of Pharmacology and Therapeutics

Professional appointments:

• Since 2021 – Member of the working group on Endocrine Disruptors, French Agency for Food, Environmental and Occupational Health & Safety (ANSES)
• Since 2020 – Member of the working group on Biomarkers of exposure, French Agency for Food, Environmental and Occupational Health & Safety (ANSES)
• Since 2019 – Member of the Clinical Pharmacology Committee, French agency for AIDS and viral hepatitis research (ANRS, Agence nationale de recherches sur le sida et les hépatites virales)
• Since 2019 – Member of the French National Academy of Pharmacy
• Since 2019 – Member of the project selection committee, French National Research Program for Environmental and Occupation Health (PNREST), French Agency for Food, Environmental and Occupational Health & Safety (ANSES)
• Since 2017 – Member of the Regional Committee for Coordination against HIV/AIDS (COREVIH Nouvelle Aquitaine), Regional Health Agency (ARS Nouvelle Aquitaine)
• Since 2017 – Member of the Transplantation Committee, University Hospital of Poitiers
• 2014-2021 – Member (elected) of the Hospital Medical Committee (Comission Medicale d’Etablissement), University Hospital of Poitiers
   
• Author and co-author of more than 50 articles in peer-reviewed journals and 11 book chapters
   
• Recipient of research grants from National Center for Scientific Research (CNRS) 2020 ; French National Research Program for Environmental and Occupation Health (PNREST), French Agency for Food, Environmental and Occupational Health & Safety (ANSES) 2018 ; Fondation de France : Public Health and Environnement 2016 ; National Institute of Health and Medical Research (INSERM, ITMO Public Health) 2016

Employment

• Since 2014: Associate Professor in the Pharmacology, Toxicology Department, University Hospital of Limoges/ INSERM U1248, University of Limoges, Limoges (France)
• 2010-2014: Assistant Professor in the Pharmacology, Toxicology Department, University Hospital of Limoges/ INSERM U1248, University of Limoges, Limoges (France)
• 2008-2011: PhD at the INSERM U850, University of Limoges, Limoges (France)
• 2004-2008: Pharmacy residency at the University Hospital of Limoges, Limoges (France)
• 1998-2004: PharmD at the University of Toulouse (Faculty of Pharmacy), Toulouse (France)

Education & Certification

• 2019 Accreditation to supervise research (HDR – French postdoctoral degree)
• 2011 PhD degree, Université Limoges, France
• 2008 PharmD degree, Faculty of Pharmacy, Toulouse, France
• 2007 Master degree, Université Paris V, Paris, France

Professional Activities

Research interest:

• Pharmacogenetics
• Pharmacometrics
• Application of machine learning to drug individualisation

Awards:

• IFCC-Gérard Siest Award (Young Scientist Award for Distinguished Contributions in Pharmacogenetics) 2020
• Award of the French Society of Pharmacology and Therapeutics, 2015 and 2017

Invited conference and oral communications:

• 26 oral communications (12 in France and 14 abroad)
• 9 invited conferences Academic and Industry (5 in France and 4 abroad)

Positions in learned societies:

• Member of the ISOP-ACCP Clinical Pharmacometrics Special Interest Group Steering Committee (Chair Dr. M. Neely) 2017-2020
• Co-chair of Pharmacometrics committee of IATDMCT since 2018

Membership in learned societies:

• Member of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
• Member of European Association for Clinical Pharmacology and Therapeutics (EACPT)
• Member of Société Française de Pharmacologie et Thérapeutique (SFPT)
• Member of groupe Suivi Thérapeutique Pharmacologique (groupe STP) of SFPT
• Member of Réseau National de Pharmacogénétique (RNPGx)

Consensus conferences:

• Participated in 2 international consensus conferences about immunosuppressive drugs (Tacrolimus and MMF)

Number of publications:

• 78 peer-reviewed manuscripts

Employment

• 04/2020 - present – Head of Scientific Research Department, the Second Xiangya Hospital of Central South University, China
• 01/2020 - present – Director of Toxicology Counseling Center of Hunan Province (TCCH), China
• 09/2017 - present – Associate Professor of Pharmacy, the Second Xiangya Hospital of Central South University, China
• 05/2013 - 06/2014 – Postdoctoral Research Fellow, University of Illinois at Chicago, USA
• 07/2010 - 08/2017 – Clinical Pharmacist, the Second Xiangya Hospital of Central South University, China

Education & Certification

• 2010 – Ph.D. in Pharmacology, Central South University, China

Professional Activities

Executive and committee positions held:

• 07/2020 - present – Standing committee member of Clinical toxicology Committee Chinese Society of Toxicology (CST)
• 09/2019 - present – Councilor of IATDMCT
• 10/2018 - present – Chair of Young Scientist Committee, Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society (CHINA-TDM)
• 09/2018 - present – Member of Anti-Infective Drugs Committee, IATDMCT
• 09/2019 - present – Member of Communications Committee, IATDMCT
• 09/2018 - present – Member of TDM in Oncology Committee, IATDMCT
• 09/2016 - present – Member of Young Scientist Committee, IATDMCT
• 07/2015 - present – Member of Pharmacometrics Committee, Chinese Pharmacological Society

Activities in IATDMCT:

• [Poster and video presentation] IATDMCT 2020 Virtual Congress, Sept 14-16
• [Co-Chair of Symposium, Invited speaker]. IATDMCT Congress 2019; Sept 22-26, 2019, Foz do Iguassu, Brazil
• [Executive chair]. The First CHINATDM-IATDMCT Young Scientist Joint Symposium at the 9th International Xiangya Clinical Pharmacy Forum; Sept 5-7, 2019, Changsha, China
• [Guest speaker]. The Third JSTDM-IATDMCT Young Scientist Joint Symposium at the 36th Annual Meeting of the Japanese Society of Therapeutic Drug Monitoring; May 25-26, 2019, Tokyo, Japan
• [Oral presentation]. IATDMCT Congress 2018; Sept 16-19, 2018, Brisbane, Australia
• [Poster presentation]. IATDMCT Congress 2017; Sept 24-27, 2017, Kyoto, Japan

Academic editorial position:

• 05/2021 – present – Lead guest editor of Frontiers in Oncology

Publications:

• Published 70 research papers in Science Citation Index journals